Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

RSS icon
Thumbnail

Humana changes health services business name to CenterWell

Health insurance giant Humana has rebranded its payer-agnostic healthcare services business, including its Partners in Primary Care and Family Physicians Group, to CenterWell.

New Walgreens CEO takes over

Rosalind Brewer has officially taken over as CEO of Walgreens Boots Alliance as of March 15.

 

 

Thumbnail

AI for CT angiography gets go-ahead

The FDA has greenlit an AI algorithm that automatically measures dilation in the heart’s right ventricle on CT images.

Is COVID-focused AI ready for legal scrutiny?

Affronts against privacy and equality—real, perceived or ginned up—may fuel lawsuits by patients whose COVID care incorporated AI.

Wrist-based early alert for COVID cleared for sale in Europe

An MIT spinoff based in Boston and Milan in Italy has earned CE certification for software that flags respiratory infection in wearers of the company’s smartwatch devices.

Thumbnail

Healthcare consolidation deserves stronger antitrust examination

More consolidation across the healthcare sector is on the horizon thanks in part to the COVID-19 pandemic, according to an opinion by Commonwealth Fund leaders published in Harvard Business Review.

Portable MRI enhanced by AI cleared for prostate imaging

A manufacturer of compact MRI machines that leverage AI to upgrade image quality has received FDA’s blessing to market its technology in the U.S.

COVID crisis burnishes AI’s promise while magnifying chinks in its armor

The COVID crisis has spurred clinical researchers to look myriad ways AI might help win the war against the virus. Has the investigatory boomlet ended up raising as many nettlesome concerns as positive possibilities?

Displaying 1737 - 1744 of 6647

Around the web

Cardiovascular Business
Q&A: Why are cardiovascular devices involved in so many recalls? FDA policies may be to blame

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Cardiovascular Business
Cardiologist compensation still rising, especially in invasive and interventional cardiology

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Cardiovascular Business
FDA’s tirzepatide decision creates uncertainty for patients—and leads to a lawsuit

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup